by Eclosion Team | Jun 28, 2017 | Uncategorized
Archamps (France) and Geneva (Switzerland), June 28th, 2017 at 6:00pm CEST. Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today that world-renowned diabetes experts Professor...
by Eclosion Team | Jun 27, 2017 | Uncategorized
Archamps (France) and Geneva (switzerland), June 27th, 2017 at 6:00 pm CEST Genkyotex (Euronext Paris & Brussels: FR00011790542 – GKTX.pa), a biopharmaceutical company and the leader in NOX therapies, announced today that it has begun enrolling patients into the...
by Eclosion Team | Jun 19, 2017 | Uncategorized
Geneva, Switzerland, 19 June 2017 – 7:30am CEST : – GeNeuro (Euronext Paris : CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for autoimmune diseases, announced today that the first patient has been treated in its Australian...
by Eclosion Team | Jun 12, 2017 | Uncategorized
Geneva (Switzerland), 12 june 2017 – 7:30am CEST : – GeNeuro (Euronext Paris : CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, announced today data supporting the link between...